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Abstract 
Objective: To describe recent legislation in Idaho that granted pharmacists autonomous prescriptive authority for epinephrine  
auto-injectors. 
Practice Innovation: States have taken action to increase access to epinephrine auto-injectors by allowing them to be stocked and 
prepositioned at locations where individuals may encounter allergens. All 50 states have allowed schools to maintain stock supplies 
of epinephrine auto-injectors and 26 states have allowed other entities, such as summer camps, daycare centers, gymnasiums, and 
restaurants to begin stocking product as well. In 2016, legislation in Idaho pursued entity stocking while simultaneously granting 
pharmacists autonomous prescriptive authority for epinephrine auto-injectors. 
Results: Idaho legislation granted prescriptive authority for pharmacists for epinephrine auto-injectors not just for individual patients, 
but also for authorized entities. No collaborative practice agreement is necessary. To receive an epinephrine auto-injector, an agent 
or employee of an authorized entity must present proof that they have completed an appropriate training program. Pharmacists are 
provided liability protections when prescribing in good faith to an authorized entity. 
Conclusion: Idaho’s legislation provides a potential model for pharmacist prescriptive authority for epinephrine auto-injectors that 
other states may consider pursuing in the years ahead. 
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In recent years, states have taken action to increase access to 
epinephrine auto-injectors by allowing them to be stocked 
and prepositioned at locations where individuals may 
encounter allergens.1 Several reasons underpin this. First, life-
threatening allergic reactions to foods, insect stings, or other 
substances are unpredictable and delays in treatment can 
increase the risk of fatality.2 Second, epinephrine provides a 
powerful antidote to anaphylactic reactions, with a strong 
safety profile and limited risk of adverse effects and no 
contraindications.3 Third, certain epinephrine products are 
supplied as auto-injectors, which can be used safely and 
appropriately by laypersons.4 Some auto-injectors are even 
equipped with audio instructions to guide a layperson 
through appropriate use in an emergency. Fourth, studies 
show that 15 to 25% of epinephrine administrations were to 
individuals who had no previous known allergies.5-6 Thus, 
epinephrine auto-injectors are generally safe and easy to use 
by laypersons, and timely administration can mitigate 
unpredictable life-threatening allergic reactions. 
As of May 2016, all 50 states and the District of Columbia 
have laws that allow schools to stock epinephrine in primary 
and secondary schools with some positive results already  
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documented.1 A study in the New York public school district 
revealed epinephrine was administered 338 times over a five-
year period, and only 20.7% of administrations were to 
students with a medication administration form for 
epinephrine on file.7 In the Akron (OH) school district, two 
children were rescued with epinephrine in the first year of 
the legislation taking effect.8 Given the positive outcomes 
achieved in schools, patient advocacy groups have started 
advancing legislation to broaden epinephrine-stocking laws 
beyond schools, such as allowing auto-injectors to be pre-
positioned at summer camps, daycare centers, gymnasiums, 
and restaurants, among other facilities. Currently, 26 states 
allow such non-school entities to stock epinephrine.1,9 
 
In 2016, legislation was signed into law in Idaho that 
expanded the authority of entities beyond schools to stock 
epinephrine auto-injectors.10 Idaho’s legislation -- Senate Bill 
1322a -- was unique, however, it that it simultaneously 
granted pharmacists autonomous prescriptive authority for 
epinephrine auto-injectors.11 Idaho is among the first state to 
grant such broad prescriptive authority for pharmacists not 
just for individual patients, but also for entities. This 
manuscript will highlight the Idaho legislation and experience 
as a model for other states considering such legislation. 
 
Core Elements of Idaho Senate Bill 1322a 
There are two core components of the Idaho legislation: 
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1. Authorization for Entities to Maintain Epinephrine Auto-
Injector Supply 
While 26 states have now passed legislation to allow non-
schools to stock epinephrine, there are slight variations 
across states, generally in the definition of authorized 
entities.1 Idaho’s bill intends to define “authorized entity” 
broadly, recognizing any organization “at which allergens 
capable of causing anaphylaxis may be present.” The bill 
offered a non-exclusive list of such entities: “recreation 
camps, colleges and universities, day care facilities, youth 
sports leagues, amusement parks, restaurants, places of 
employment and sports arenas.”11 
 
Several amendments to existing law were made to remove 
any barrier to authorized entities stocking epinephrine. For 
example, the statute outlining criminal penalties for the sale 
or the possession of a legend drug outside of a valid 
prescription drug order exempted epinephrine auto-injectors 
if in compliance with other provisions in Senate Bill 1322a. 
Similarly, the statute limiting prescriptions to a valid 
“prescriber-patient relationship” with a documented patient 
evaluation also exempted epinephrine auto-injectors. 
 
The legislation required authorized entities to comply with 
the following: 
• Epinephrine auto-injectors must be stored in a 
“location readily accessible in an emergency and in 
accordance with proper instructions for use.” 
• An employee or agent of the authorized entity must 
complete a training program by a “nationally 
recognized organization experienced in training 
laypersons in emergency health treatment” in order 
to administer epinephrine. The bill delineated 
certain required topics, including how to recognize 
allergic reactions and anaphylaxis, standard 
procedures of storage, administration, disposal, and 
emergency follow-up procedures. 
• The authorized entity must contact emergency 
medical services as soon as possible following an 
administration.11 
An authorized entity may have its employee or agent who has 
completed the specified training program directly administer 
the epinephrine auto-injector to any individual who he or she 
“believes in good faith to be experiencing anaphylaxis, 
regardless of whether the individual has previously been 
diagnosed with an allergy.” Alternatively, the employee or 
agent could provide the epinephrine auto-injector to the 
patient, parent, guardian or caregiver for immediate 
administration. Liability protections against injuries or related 
damages are provided to authorized entities who act in good 
faith and follow the procedures outlined in the bill, though 
such protections do not apply to “acts or omissions 
constituting gross negligence.”11 
 
2. Pharmacist Prescriptive Authority for Epinephrine Auto-
Injectors 
The Idaho bill contained a provision granting pharmacists the 
ability to prescribe epinephrine auto-injectors under certain 
circumstances. The reason for this was two-fold. First, 
epinephrine auto-injections are still prescription products, 
and it poses a barrier to access to require an entity to first 
schedule an appointment with a traditional prescriber in 
order to gain access to this product. Idaho already ranks low 
on lists of physicians per capita, and it is likely a misallocation 
of limited physician time to require a restaurant owner, for 
example, to set up an appointment with a primary care 
physician as a pre-requisite to receiving a prescription for an 
epinephrine auto-injector. 
 
Second, there are infrequent but not uncommon reports of 
patients experiencing allergic or anaphylactic reactions 
seeking emergency care at a pharmacy.12-15 In one such 
report, a pharmacist refused to provide an epinephrine auto-
injector to a patient as the pharmacist cited that a 
prescription was necessary; the patient died shortly 
thereafter.15 While it seems unlikely that a regulatory board 
would pursue discipline against a pharmacist for engaging in a 
life-saving action, and some states may already cover such 
action under Good Samaritan laws, it none-the-less seemed 
beneficial to explicitly remove any doubt that pharmacists 
may have. 
 
The legislation grants an unrestricted model of pharmacist 
prescriptive authority.16-17 Thus, no collaborative practice 
agreement is necessary, and there is no statewide protocol to 
follow. Pharmacists are expected to act “in good faith and 
exercise reasonable judgment” in prescribing epinephrine 
auto-injectors. The legislative language was based heavily off 
of a bill that had successfully passed in the previous Idaho 
legislative session, granting pharmacist prescriptive authority 
for opioid antagonists such as naloxone.18 
 
Specifically, the bill authorized pharmacists to prescribe to: 
(1) “A person at risk of experiencing anaphylaxis; 
(2) A person in a position to assist a person at risk of 
experiencing anaphylaxis;  
(3) A person who, in the course of the person's official 
duties or business, may encounter a person 
experiencing anaphylaxis; and 
(4) A person who, in the opinion of the prescriber or 
pharmacist, has a valid reason to be in possession of 
an epinephrine auto-injector.”11 
 
Thus, the prescriptive authority is broad and extends beyond 
a patient currently experiencing anaphylaxis. The bill also 
explicitly states that a pharmacist or other health care 
practitioner may prescribe in the name of an authorized 
entity. Unlike an individual patient, an authorized entity must 
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first present proof to the pharmacist (or other prescriber) 
that at least one employee or agent has completed a training 
program meeting the requirements outlined in statute. 
Pharmacists were granted liability protections against injuries 
or other damages that result from the actions of an 
authorized entity to whom they prescribed. 
 
The Legislative Process 
The bill encountered no formal opposition as it made its way 
through the legislature; it passed unanimously in both the 
House and Senate, and was signed into law on March 30, 
2016 with an effective date of July 1, 2016.  
 
Legislators appropriately raised several questions during the 
hearings on the bill. First, some questioned how the training 
requirements for agents or employees of entities stocking 
epinephrine would be enforced. The enforcement of the bill 
would fall under the state’s Board of Pharmacy, and since 
authorized entities are not licensees or registrants of the 
Board, enforcement would pose challenges. To enhance 
enforcement, an amendment was drafted that stated an 
authorized entity must first present proof to a prescriber that 
at least one employee or agent has completed a national 
training program prior to receiving a prescription, such as 
certificate of completion of a qualifying program. This thus 
places the enforcement of training at the level of the 
prescriber. 
 
Another question was raised over if laypersons at authorized 
entities will engage in appropriate follow-up procedures such 
as removing the patient from the precipitating allergen.  
Some expressed fear that a layperson would administer 
epinephrine and believe that this action alone is sufficient for 
emergency treatment. These concerns were addressed with 
an amendment that required a layperson to contact 
emergency medical services as soon after administration as 
possible. Further, the training program required of agents or 
employees of authorized entities also necessitates training on 
appropriate follow-up procedures following administration.  
 
Lastly, a question was raised over the rising cost of 
epinephrine auto-injectors. One legislator presented data 
that the price has risen by more than 400% since 2007.19 It is 
unlikely that pharmacist prescriptive authority will drive 
further price increases. Conversely, because pharmacists can 
prescribe any FDA-approved epinephrine auto-injector, 
pharmacists could work with patients or entities to find the 
most appropriate device, taking cost into consideration. In 
addition, it was noted that authorized entities seeking 
epinephrine would likely pay cash for the medication, as 
insurance was unlikely to cover the cost in whole or in part 
for an entity. 
 
 
Discussion 
Idaho’s bill thus grants prescription authority for epinephrine 
auto-injectors to pharmacists for both individuals and 
entities, and as such it stands in contrast to the approach 
other states have taken. Some states, for example, have 
limited pharmacists’ ability to administer epinephrine without 
a prescription to treatment of an adverse event stemming 
from an immunization.1 In a recent Texas bill, prescriptive 
authority was limited to patients currently experiencing a life-
threatening anaphylactic reaction, and thus did not include 
other patients.20 Texas’s bill and rules also required specific 
notification requirements to a patient’s primary care 
physician, recordkeeping requirements of such notifications, 
and prohibitions on remuneration for epinephrine 
administration.20 Idaho’s bill, by contrast, was silent on these 
requirements. Idaho’s law combines broad pharmacist 
prescriptive authority for epinephrine auto-injectors with the 
allowance for authorized entities to stockpile the product. As 
such, it provides a potential model for other states to pursue 
in the years ahead. 
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